GLYCOSENSORS AND DIAGNOSTICS, LLC

Athens, GA · Medtech · Defunct

GlycoSense, a flow cytometry-based analytical instrument using glycan-specific reagent beads to monitor protein glycosylation during biopharmaceutical production

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · lectenz.com

Sector: Medtech
Headquarters: Athens, GA
Total capital: $3.3M

Federal grants: $3.3M; 5 awards · 2017–2023; Rank in peer group#71 of 112
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 4; 7 pending · first 2017; Rank in peer group#14 of 112

Capital timeline

Latest events

Sep 2023Federal grantHealth and Human S · Phase II · A new approach to monitoring glycosylation during glycoprotein production$989K
Mar 2020Federal grantHealth and Human S · Phase I · Development of a suite of high-specificity fucose binding reagents$450K
Jan 2018Federal grantHealth and Human S · Phase II · High-specificity affinity reagents for the detection of glycan sialylation$1M
Sep 2017Federal grantHealth and Human S · Phase I · A rapid method for monitoring in vitro glycoengineering$300K
Aug 2017Federal grantHealth and Human S · Phase I · Reagents specific for all N-glycans$505K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 112 peers

Line = median

Medtech · Instrument

Federal grantsBelow median
Granted patents#14 · top 13%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 11

Apr 4, 2024PendingReagents For Detection Of N-glycosylationUSPTOApplication 18241459
Sep 6, 2022GrantedSialic Acid Binding PolypeptideUSPTOUS 11,434,479
May 11, 2021GrantedCarbohydrate-binding ProteinUSPTOUS 11,001,824

Show all 11 patent records

Reagents For Detection Of N-glycosylationApr 4, 2024 · Application 18241459Pending
Sialic Acid Binding PolypeptideSep 6, 2022 · US 11,434,479Granted
Carbohydrate-binding ProteinMay 11, 2021 · US 11,001,824Granted
Carbohydrate-binding ProteinJul 23, 2019 · US 10,358,637Granted
Glycan-specific Analytical ToolsSep 13, 2018 · Application 15916578Pending
Glycomimetics To Inhibit Pathogen-host InteractionsMar 28, 2017 · US 9,605,014Granted
Carbohydrate-binding ProteinApplication PCTUS2015026374Pending
Sialic Acid Binding PolypeptideApplication PCTUS2018029079Pending
Glycomimetics To Inhibit Pathogen-host InteractionsApplication PCTUS2013031238Pending
Glycoprofiling With Multiplexed Suspension ArraysApplication PCTUS2012027211Pending
Glycan-specific Analytical ToolsApplication PCTUS2009067582Pending

CORTICOMETRICS LLCSimilar federal contract value in Medtech · null in contracts
REDOLYNT, LLCSimilar federal contract value in Medtech · null in contracts
MANTEL TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
EXPANSE BIO LLCSimilar federal contract value in Medtech · null in contracts
DELTA CHASE, LLCSimilar federal contract value in Medtech · null in contracts
ERIK PAGE AND ASSOCIATES, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.